1: Anwar S, Mohammad T, Azhar MK, Fatima H, Alam A, Hasan GM, Islam A, Kaur P, Hassan MI. Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease. Int J Biol Macromol. 2023 Jun 12:125364. doi: 10.1016/j.ijbiomac.2023.125364. Epub ahead of print. 19(3):653. doi: 10.3390/ijms19030653. 3: Tomita Y, Smith E, Palethorpe HM, Nakhjavani M, Yeo KKL, Townsend AR, Price TJ, Yool AJ, Hardingham JE. In Vitro Synergistic Inhibition of HT-29 Proliferation and 2H-11 and HUVEC Tubulogenesis by Bacopaside I and II Is Associated with Ca2+ Flux and Loss of Plasma Membrane Integrity. Pharmaceuticals (Basel). 2021 May 6;14(5):436. doi: 10.3390/ph14050436.
合成参考文献
参考文献:10.1248/cpb.54.907 摘要:Murthy PB, Raju VR, Ramakrisana T, Chakravarthy MS, Kumar KV, Kannababu S, Subbaraju GV. Estimation of twelve bacopa saponins in Bacopa monnieri extracts and formulations by high-performance liquid chromatography. Chem Pharm Bull (Tokyo). 2006 Jun;54(6):907–11. doi: 10.1248/cpb.54.907.